Methyl N-[4,6-diamino-2-[1-(thiophen-2-ylmethyl)pyrazolo[5,4-b]pyridin-3-yl]pyrimidin-5-yl]-N-methylcarbamate
C18H18N8O2S — CID 155546193
Data last refreshed: (MolForge compound catalog, from PubChem)
About Methyl N-[4,6-diamino-2-[1-(thiophen-2-ylmethyl)pyrazolo[5,4-b]pyridin-3-yl]pyrimidin-5-yl]-N-methylcarbamate
Methyl N-[4,6-diamino-2-[1-(thiophen-2-ylmethyl)pyrazolo[5,4-b]pyridin-3-yl]pyrimidin-5-yl]-N-methylcarbamate (PubChem CID 155546193) has the molecular formula C18H18N8O2S and a molecular weight of 410.46 g/mol. Its IUPAC name is methyl N-[4,6-diamino-2-[1-(thiophen-2-ylmethyl)pyrazolo[5,4-b]pyridin-3-yl]pyrimidin-5-yl]-N-methylcarbamate.
Molecular Properties
| Compound Name | Methyl N-[4,6-diamino-2-[1-(thiophen-2-ylmethyl)pyrazolo[5,4-b]pyridin-3-yl]pyrimidin-5-yl]-N-methylcarbamate |
|---|---|
| PubChem CID | 155546193 |
| Molecular Formula | C18H18N8O2S |
| Molecular Weight | 410.46 g/mol |
| Exact Mass | 410.13 |
| IUPAC Name | methyl N-[4,6-diamino-2-[1-(thiophen-2-ylmethyl)pyrazolo[5,4-b]pyridin-3-yl]pyrimidin-5-yl]-N-methylcarbamate |
| SMILES | COC(=O)N(C)c1c(N)nc(-c2nn(Cc3cccs3)c3ncccc23)nc1N |
| InChI | InChI=1S/C18H18N8O2S/c1-25(18(27)28-2)13-14(19)22-16(23-15(13)20)12-11-6-3-7-21-17(11)26(24-12)9-10-5-4-8-29-10/h3-8H,9H2,1-2H3,(H4,19,20,22,23) |
| InChIKey | IOMLFPPXSLEFST-UHFFFAOYSA-N |
| XLogP | 2.37 |
| TPSA | 138.07 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 10 |
| Rotatable Bonds | 4 |
| Heavy Atoms | 29 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 410.46 |
| LogP ≤ 5 | 2.37 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 10 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 155546193 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.